Biome Australia Ltd (AU:BIO) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Biome Australia Ltd has announced that they anticipate a record-breaking first quarter in FY25, with sales revenue expected to exceed $4.0 million. This follows the previous quarter’s high of $3.8 million, signaling ongoing growth for the company that specializes in probiotics and complementary medicines aimed at improving health outcomes. Biome’s products, which are backed by clinical research, cater to various health concerns and are distributed both locally and internationally.
For further insights into AU:BIO stock, check out TipRanks’ Stock Analysis page.